HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TNF-α expression in neutrophils and its regulation by glycogen synthase kinase-3: a potentiating role for lithium.

Abstract
Glycogen synthase kinase 3 (GSK-3) is associated with several cellular systems, including immune response. Lithium, a widely used pharmacological treatment for bipolar disorder, is a GSK-3 inhibitor. GSK-3α is the predominant isoform in human neutrophils. In this study, we examined the effect of GSK-3 inhibition on the production of TNF-α by neutrophils. In the murine air pouch model of inflammation, lithium chloride (LiCl) amplified TNF-α release. In lipopolysaccharide-stimulated human neutrophils, GSK-3 inhibitors mimicked the effect of LiCl, each potentiating TNF-α release after 4 h, in a concentration-dependent fashion, by up to a 3-fold increase (ED50 of 1 mM for lithium). LiCl had no significant effect on cell viability. A positive association was revealed between GSK-3 inhibition and prolonged activation of the p38/MNK1/eIF4E pathway of mRNA translation. Using lysine and arginine labeled with stable heavy isotopes followed by quantitative mass spectrometry, we determined that GSK-3 inhibition markedly increases (by more than 3-fold) de novo TNF-α protein synthesis. Our findings shed light on a novel mechanism of control of TNF-α expression in neutrophils with GSK-3 regulating mRNA translation and raise the possibility that lithium could be having a hitherto unforeseen effect on inflammatory diseases.
AuthorsMiriam S Giambelluca, Geneviève Bertheau-Mailhot, Cynthia Laflamme, Emmanuelle Rollet-Labelle, Marc J Servant, Marc Pouliot
JournalFASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 28 Issue 8 Pg. 3679-90 (Aug 2014) ISSN: 1530-6860 [Electronic] United States
PMID24803542 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© FASEB.
Chemical References
  • CREB1 protein, human
  • Cyclic AMP Response Element-Binding Protein
  • Cytokines
  • Indoles
  • Lipopolysaccharides
  • Maleimides
  • NF-kappa B
  • Protein Kinase Inhibitors
  • RNA, Messenger
  • SB 216763
  • Tumor Necrosis Factor-alpha
  • lipopolysaccharide, Escherichia coli O111 B4
  • Glycogen Synthase Kinase 3
  • glycogen synthase kinase 3 alpha
  • Lithium Chloride
Topics
  • Animals
  • Cells, Cultured
  • Cyclic AMP Response Element-Binding Protein (metabolism)
  • Cytokines (biosynthesis, genetics)
  • Glycogen Synthase Kinase 3 (antagonists & inhibitors, physiology)
  • Humans
  • Indoles (pharmacology)
  • Inflammation
  • Lipopolysaccharides (pharmacology)
  • Lithium Chloride (pharmacology)
  • Maleimides (pharmacology)
  • Mice
  • Models, Animal
  • NF-kappa B (metabolism)
  • Neutrophil Infiltration
  • Neutrophils (enzymology, metabolism)
  • Protein Biosynthesis (drug effects)
  • Protein Kinase Inhibitors (pharmacology)
  • RNA, Messenger (biosynthesis, genetics)
  • Signal Transduction (drug effects, physiology)
  • Subcutaneous Tissue
  • Tumor Necrosis Factor-alpha (biosynthesis, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: